Maintaining low HIV seroprevalence in populations of injecting drug users

Don C. Des Jarlais*, Holly Hagan, Samuel R. Friedman, Patricia Friedmann, David Goldberg, Martin Frischer, Steven Green, Kerstin Tunving, Bengt Ljungberg, Alex Wodak, Michael Ross, David Purchase, Margaret E. Millson, Ted Myers

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

228 Citations (Scopus)

Abstract

Objectives. - To describe prevention activities and risk behavior in cities where human immunodeficiency virus (HIV) was introduced into the local population of injecting drug users (IDUs), but where seroprevalence has nevertheless remained low (Interventions. - A variety of HIV prevention activities for IDUs had been implemented in each of the five cities.
Results. - There were three common prevention components present in all five cities: (1) implementation of prevention activities when HIV seroprevalence was still low, (2) provision of sterile injection equipment, and (3) community outreach to IDUs. Moderate levels of risk behavior continued with one third or more of the IDUs reporting recent unsafe injections.
Conclusions. - In low-seroprevalence areas, it appears possible to severely limit transmission of HIV among populations of IDUs, despite continuing risk behavior among a substantial proportion of the population. Pending further studies, the common prevention components (beginning early, community outreach, and access to sterile injection equipment) should be implemented wherever populations of IDUs are at risk for rapid spread of HIV.
Original languageEnglish
Pages (from-to)1226-1231
Number of pages6
JournalJAMA
Volume274
Issue number15
DOIs
Publication statusPublished - 18 Oct 1995
Externally publishedYes

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Maintaining low HIV seroprevalence in populations of injecting drug users'. Together they form a unique fingerprint.

Cite this